Alveo Technologies recently announced a collaboration with Janssen Pharmaceuticals, part of Johnson & Johnson, to advance the company’s at-home testing platform that detects viral infections,...
Two-thirds of US adults reported that prescription drug prices have increased either “a little” or “a lot” since 2017, the first year of the Trump administration, according to a...
Roche recently announced the development of a serology test to detect antibodies in individuals who have been exposed to COVID-19.
For more coronavirus updates, visit our resource page,...
The National Institutes of Health (NIH) and Foundation for the NIH recently announced it is joining forces with more than a dozen biopharmaceutical companies to boost COVID-19 drug...
The lack of rapid and accurate molecular diagnostic testing has impeded the healthcare system’s response to the COVID-19 pandemic. Recently, researchers developed rapid, easy-to-implement, and...
A recent study found that 68 percent of COVID-19 patients who received compassionate-use remdesivir showed clinical improvement, but measurements of efficacy will require ongoing controlled trials to...
A treatment for hemophilia is the latest FDA approval seeking to improve chronic disease management.
FDA recently approved Sevenfact for the treatment of hemophilia A or B with inhibitors in adults...
The Pfizer Foundation recently announced the commitment of $40 million in medical and charitable cash grants to help combat the global health effects of the COVID-19 pandemic.
For more...
Mylan recently announced that the proposed pharmaceutical merger with Upjohn, a division of Pfizer, is delayed due to the COVID-19 pandemic.
For more coronavirus updates, visit our resource page,...
Biosimilar reviews confirm any differences between a potential biosimilar and its reference product, but new research shows that these reviews may need to provide more information about efficacy to...
MassBio and Bayer recently announced the Center for Regulatory Excellence, a first-of-its-kind forum that will be open to all startups and academia in the biotech and digital health space to learn from...
There are 362 investigational cell and gene therapies currently in clinical development, a 20 percent increase from 2018, according to a recent report from Pharmaceutical Research and Manufacturers of...
The Bill and Melinda Gates Foundation, Wellcome, and Mastercard recently launched an initiative to boost drug discovery and biologics to treat patients with COVID-19.
For more coronavirus updates,...
Patients will now have access to a cheaper version of the drug at the center of a recent price gouging case. In an announcement on Feb. 28, the FDA reported that it has approved the first generic drug...
A federal judge ruling last week will significantly expand the public’s right to access results of clinical trials studying drugs and medical devices, according to a recent press release.
Judge...
Remdesivir is effective in treating Middle East respiratory syndrome (MERS) and severe acute respiratory syndrome (SARS), but also may be a successful drug for patients with coronavirus, or COVID-19,...
The US Justice Department announced that pharmaceutical company Sanofi SA agreed to pay $11.85 million to resolve Medicare fraud accusations involving a recent charity kickback probe.
Sanofi...
The net cost of prescription drugs rose over three times faster than the rate of inflation over the last decade, according to researchers from the University of Pittsburgh’s Health Policy...
Two members of the United States Committee on Finance made a final document request to pharmacy benefit manager Express Scripts, owned by Cigna, and warned that failure to comply will result in a...
The Institute for Clinical and Economic Review’s (ICER) final evidence report assessing the clinical effectiveness and economic value of three acute treatments for migraines had more favorable...
